February 28, 2011

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 61 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2011 ACS

Patent Number: US 7875729
Title: Process for preparation of trans-asenapine employing stereoselective hydrogenation of a dibenzoxepine intermediate
Inventor(s): Zhu, Jie; Keltjens, Rolf; Firet, Judith Janneke
Patent Assignee(s): Synthon B.V., Neth.
Source: PCT Int. Appl., 29pp. CODEN: PIXXD
Language: English
Abstract:
Asenapine and related trans-isomer bicyclic compds. can be obtained by reducing a compound of Formula (C) to preferentially form a trans-isomer compound of Formula (D), followed by subsequent ring closure to form a   compound of Formula (B) such as asenapine.  A method for preparing asenapine (I), and related trans-isomer bicyclic compds., is disclosed.  The  stereoselectivity arises via the hydrogenation of a dibenzoxepine    dicarboxylate intermediate II (R1 and R2 independently = alkyl, alkynyl or aralkyl group).  The reduction product of II (R1 and R2 = Me) then undergoes heterocyclization with methylamine to provide the desired I.

 

View the full-text patent from USPTO.

Recent News


    August 7, 2015 | CAS Announces the 2015 SciFinder
    Future Leaders in Chemistry and First-Ever Alumni
    Program
   
    August 3, 2015 | New STN Breaks Ground with
    Markush Structure Search and Enhanced Content
    for Intellectual Property Exploration and Research
   
    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org